PRESENTATIONS
Introduction to the Parents Translational Research Center, including overview along with three core projects: Parents as Interventionists for Moderate Drug Abusing Adolescents, or Developing a Consumer Guide to Adolescent Drug Treatment, or CRAFT: Helping Parents Initiate or Support their Adolescent’s Treatment.
Characteristics and Outcomes of Insured Patients Treated with Extended Release Naltrexone (XR-NTX) or Oral Alcohol Dependence Medications: Winter 2011 presentation by Mady Chalk, Ph.D. discussing research findings that patients treated with alcoholism medications had lower healthcare utilization and that Naltrexone XR (injectable extended release) showed advantages over FDA-approved oral medications in terms of healthcare utilization and costs.
Performance Measurement in Addictions Treatment Programs: April 2007 presentation by Deni Carise, Ph.D. to members of the Colorado State Legislature discussing ways performance should be measured in substance abuse treatment and models for performance based contracting.
Reconsidering Addiction Treatment by A. Thomas McLellan, Ph.D.; October 2007 presentation before members of the North Carolina State Legislature discussing new ways to look at treatment effectiveness and legislators’ options for promoting accountability through performance improvement initiatives. (Also see Performance Based Contracting: Some Things to Consider, Kimberly Johnson, former SSA Director State of Maine; and Funding Tools for Service Systems, by Mady Chalk, Ph.D.)
Public Responsibility and Addiction Treatment: January 2008 presentation before Kansas legislative committees by Mady Chalk, Ph.D. discussing public and private financing mechanisms for addiction treatment; using outcomes and performance measures to improve quality; and purchasing alternatives for publicly funded systems.
What’s Wrong with Addiction Treatment: What Could Help: January 2008 presentation by A. Thomas McLellan, Ph.D. before Connecticut legislators discussing treatment effectiveness; addiction as a chronic relapsing disease with implications for treatment and funding; ways to stretch limited State dollars, and basic principles for evaluating treatment effectiveness.
Mady Chalk, Ph.D. “Reconsidering Addiction Treatment,” a presentation on the role of outcome and performance measurement in quality improvement, before the Select Committee on Mental Health and Substance Abuse, Wyoming State Legislature, May 15, 2006.
Antoinette Krupski, Ph.D., “Expanding Alcohol/Drug Treatment: An Investment in Health Care Cost Containment and Public Safety,” a discussion of cost offsets realized in Washington State from AOD treatment, before the Select Committee on Mental Health and Substance Abuse, Wyoming State Legislature, May 15, 2006.
Ken C. Winters, Ph.D.: "Effects of Drugs of Abuse on the Developing Brain". Philadelphia, PA, November 2004.
Camilleri Presentation at CPDD Conference: "Are Prescription Opiate Users Different from Heroin Users?". San Juan, P.R., June 14, 2004.
McLellan Presentation at NADAAC Meeting: "Myths About and the Future of Addiction Treatment". Washington, D.C., September 15, 2003.
Also available: presentations from AHSR Conference 2004.
Behavioral
Treatments and Applications
Law
& Ethics
Center
on the Continuum of Care:
Monitoring
and Adapting Addiction Treatment
Center
for Policy Research and
Analysis
Parents Translational Research Center
Adolescents
Treatment
Research Solutions
Clinical
Trials Network
Projects-at-a-Glance
TRI Collaborators
Addiction
Severity Index (ASI)
Other
Assessment Instruments
Publications
Presentations
Archives
Training
Order
TRI Resources
Career
Opportunities
Contact
Us
Research
Briefs
Sign
up for E-Alerts